Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gordon Sussman

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Allergy|December 8, 2025
Long-Term Efficacy and Safety of Ligelizumab as Re-Treatment in Patients With Chronic Spontaneous UrticariaAna M Gimenez-Arnau, Marcus Maurer, Adam Reich, et al.
Allergy|February 1, 2022
Cannabis-related allergies: An international overview and consensus recommendationsIsabel J Skypala, Samira Jeimy, Hannelore Brucker, et al.
Clinical and Translational Allergy|July 25, 2023
In chronic spontaneous urticaria soluble FcεRI is elevated and linked to atopy and chronic inducible urticariaSherezade Moñino-Romero, Pavel Kolkhir, Zsolt Szépfalusi, et al.
Allergy|June 23, 2019
Biomarkers and clinical characteristics of autoimmune chronic spontaneous urticaria: Results of the PURIST StudyNicole Schoepke, Riccardo Asero, André Ellrich, et al.
The World Allergy Organization Journal|June 23, 2025
Diagnostic testing for chronic spontaneous urticaria with or without angioedema: The do's, don't and maybe'sJonathan A Bernstein, Ignacio Ansotegui, Riccardo Asero, et al.
The New England Journal of Medicine|October 3, 2019
Ligelizumab for Chronic Spontaneous UrticariaMarcus Maurer, Ana M Giménez-Arnau, Gordon Sussman, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|October 30, 2014
Canadian hereditary angioedema guidelineStephen Betschel, Jacquie Badiou, Karen Binkley, et al.
JAMA|February 23, 2019
Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion Among Children With Peanut Allergy: The PEPITES Randomized Clinical TrialDavid M Fleischer, Matthew Greenhawt, Gordon Sussman, et al.
Lancet (London, England)|November 26, 2023
Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trialsMarcus Maurer, Luis Felipe Ensina, Ana Maria Gimenez-Arnau, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 18, 2019
Long-Term Outcomes with Subcutaneous C1-Inhibitor Replacement Therapy for Prevention of Hereditary Angioedema AttacksTimothy Craig, Bruce Zuraw, Hilary Longhurst, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Allergy|December 8, 2025
Long-Term Efficacy and Safety of Ligelizumab as Re-Treatment in Patients With Chronic Spontaneous UrticariaAna M Gimenez-Arnau, Marcus Maurer, Adam Reich, et al.
Allergy|February 1, 2022
Cannabis-related allergies: An international overview and consensus recommendationsIsabel J Skypala, Samira Jeimy, Hannelore Brucker, et al.
Clinical and Translational Allergy|July 25, 2023
In chronic spontaneous urticaria soluble FcεRI is elevated and linked to atopy and chronic inducible urticariaSherezade Moñino-Romero, Pavel Kolkhir, Zsolt Szépfalusi, et al.
Allergy|June 23, 2019
Biomarkers and clinical characteristics of autoimmune chronic spontaneous urticaria: Results of the PURIST StudyNicole Schoepke, Riccardo Asero, André Ellrich, et al.
The World Allergy Organization Journal|June 23, 2025
Diagnostic testing for chronic spontaneous urticaria with or without angioedema: The do's, don't and maybe'sJonathan A Bernstein, Ignacio Ansotegui, Riccardo Asero, et al.
The New England Journal of Medicine|October 3, 2019
Ligelizumab for Chronic Spontaneous UrticariaMarcus Maurer, Ana M Giménez-Arnau, Gordon Sussman, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|October 30, 2014
Canadian hereditary angioedema guidelineStephen Betschel, Jacquie Badiou, Karen Binkley, et al.
JAMA|February 23, 2019
Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion Among Children With Peanut Allergy: The PEPITES Randomized Clinical TrialDavid M Fleischer, Matthew Greenhawt, Gordon Sussman, et al.
Lancet (London, England)|November 26, 2023
Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trialsMarcus Maurer, Luis Felipe Ensina, Ana Maria Gimenez-Arnau, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 18, 2019
Long-Term Outcomes with Subcutaneous C1-Inhibitor Replacement Therapy for Prevention of Hereditary Angioedema AttacksTimothy Craig, Bruce Zuraw, Hilary Longhurst, et al.
Pageof 7